Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 59.4 USD -0.87% Market Closed
Market Cap: 10.8B USD
Have any thoughts about
Catalent Inc?
Write Note

Intrinsic Value

The intrinsic value of one CTLT stock under the Base Case scenario is hidden USD. Compared to the current market price of 59.4 USD, Catalent Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CTLT Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Backtest
Catalent Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CTLT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CTLT?
Bearish
Neutral
Bullish

Fundamental Analysis

Intrinsic Value and Risks & Rewards hidden

Sign up to unlock intrinsic valuation and risk & rewards analysis.

Sign Up
Company Quality
HIDDEN
Show
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Catalent Inc

Provide an overview of the primary business activities
of Catalent Inc.

What unique competitive advantages
does Catalent Inc hold over its rivals?

What risks and challenges
does Catalent Inc face in the near future?

Has there been any significant insider trading activity
in Catalent Inc recently?

Summarize the latest earnings call
of Catalent Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Catalent Inc.

Provide P/S
for Catalent Inc.

Provide P/E
for Catalent Inc.

Provide P/OCF
for Catalent Inc.

Provide P/FCFE
for Catalent Inc.

Provide P/B
for Catalent Inc.

Provide EV/S
for Catalent Inc.

Provide EV/GP
for Catalent Inc.

Provide EV/EBITDA
for Catalent Inc.

Provide EV/EBIT
for Catalent Inc.

Provide EV/OCF
for Catalent Inc.

Provide EV/FCFF
for Catalent Inc.

Provide EV/IC
for Catalent Inc.

Show me price targets
for Catalent Inc made by professional analysts.

What are the Revenue projections
for Catalent Inc?

How accurate were the past Revenue estimates
for Catalent Inc?

What are the Net Income projections
for Catalent Inc?

How accurate were the past Net Income estimates
for Catalent Inc?

What are the EPS projections
for Catalent Inc?

How accurate were the past EPS estimates
for Catalent Inc?

What are the EBIT projections
for Catalent Inc?

How accurate were the past EBIT estimates
for Catalent Inc?

Compare the revenue forecasts
for Catalent Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Catalent Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Catalent Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Catalent Inc compared to its peers.

Compare the P/E ratios
of Catalent Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Catalent Inc with its peers.

Analyze the financial leverage
of Catalent Inc compared to its main competitors.

Show all profitability ratios
for Catalent Inc.

Provide ROE
for Catalent Inc.

Provide ROA
for Catalent Inc.

Provide ROIC
for Catalent Inc.

Provide ROCE
for Catalent Inc.

Provide Gross Margin
for Catalent Inc.

Provide Operating Margin
for Catalent Inc.

Provide Net Margin
for Catalent Inc.

Provide FCF Margin
for Catalent Inc.

Show all solvency ratios
for Catalent Inc.

Provide D/E Ratio
for Catalent Inc.

Provide D/A Ratio
for Catalent Inc.

Provide Interest Coverage Ratio
for Catalent Inc.

Provide Altman Z-Score Ratio
for Catalent Inc.

Provide Quick Ratio
for Catalent Inc.

Provide Current Ratio
for Catalent Inc.

Provide Cash Ratio
for Catalent Inc.

What is the historical Revenue growth
over the last 5 years for Catalent Inc?

What is the historical Net Income growth
over the last 5 years for Catalent Inc?

What is the current Free Cash Flow
of Catalent Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Catalent Inc.

Business Breakdown

Catalent Inc. is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for pharmaceuticals, biologics, and consumer health products. Founded in 2007, the company has rapidly grown its footprint by offering innovative solutions that enhance drug formulation and accelerate time to market. With a portfolio that spans from drug development to commercialization, Catalent’s core mission is to improve patient outcomes by ensuring that life-changing therapies reach those who need them. The company operates state-of-the-art manufacturing facilities across the globe, fostering strong partnerships with both small biotechnology firms and large pharmaceutic...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Catalent Inc

Current Assets 2.6B
Cash & Short-Term Investments 289m
Receivables 1.5B
Other Current Assets 802m
Non-Current Assets 7.2B
PP&E 3.6B
Intangibles 3.2B
Other Non-Current Assets 339m
Current Liabilities 1B
Accounts Payable 361m
Accrued Liabilities 356m
Other Current Liabilities 314m
Non-Current Liabilities 5.1B
Long-Term Debt 4.9B
Other Non-Current Liabilities 261m
Efficiency

Earnings Waterfall
Catalent Inc

Revenue
4.4B USD
Cost of Revenue
-3.4B USD
Gross Profit
953m USD
Operating Expenses
-964m USD
Operating Income
-11m USD
Other Expenses
-1B USD
Net Income
-1B USD

Free Cash Flow Analysis
Catalent Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

The quarter saw a 4%-6% decline in net revenue at $982 million due to a $85 million decrease in COVID-19 related revenue, offset by growths of 11% and 5% in Biologics and PCH respectively. Adjusted EBITDA plummeted by 38% to $115 million, and the company recorded an adjusted net loss of $19 million. Despite this, fiscal '24 guidance remains unchanged, expecting net revenue between $4.3 billion to $4.5 billion (3% growth at midpoint), adjusted EBITDA from $680 million to $760 million, and adjusted net income ranging from $113 million to $175 million.

What is Earnings Call?
Fundamental Scores

CTLT Profitability Score
Profitability Due Diligence

Catalent Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
hidden
Profitability
Score

Catalent Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CTLT Solvency Score
Solvency Due Diligence

Catalent Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Low Altman Z-Score
hidden
Solvency
Score

Catalent Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTLT Price Targets Summary
Catalent Inc

Wall Street analysts forecast CTLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTLT is 61.97 USD with a low forecast of 42.42 USD and a high forecast of 66.68 USD.

Lowest
Price Target
42.42 USD
29% Downside
Average
Price Target
61.97 USD
4% Upside
Highest
Price Target
66.68 USD
12% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CTLT?

Click here to dive deeper.

Dividends

Catalent Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CTLT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Ownership

CTLT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

CTLT News

Other Videos

Profile

Catalent Inc Logo
Catalent Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

10.7B USD

Dividend Yield

0%

Description

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. The company is headquartered in Somerset, New Jersey and currently employs 17,300 full-time employees. The company went IPO on 2014-07-31. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.

Contact

NEW JERSEY
Somerset
14 Schoolhouse Rd
+17325376200.0
www.catalent.com

IPO

2014-07-31

Employees

17 300

Officers

See Also

Discover More
What is the Intrinsic Value of one CTLT stock?

The intrinsic value of one CTLT stock under the Base Case scenario is hidden USD.

Is CTLT stock undervalued or overvalued?

Compared to the current market price of 59.4 USD, Catalent Inc is hidden .

Back to Top